ARROWHEAD PHARMACEUTICALS IN

Ticker: ARWR CUSIP: 04280A100 Class: Common Stock

Slate Path Capital LP's Holding History (CIK: 0001559706)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 2,523,500 Value ($000) $167,535 Avg Close $49.01 Range $34.38 - $72.36
Q3 2025
Shares 4,982,000 Value ($000) $171,829 Avg Close $21.98 Range $14.30 - $34.61
Q2 2025
Shares 5,232,000 Value ($000) $82,666 Avg Close $14.35 Range $9.57 - $17.49
Q1 2025
Shares 5,232,000 Value ($000) $66,656 Avg Close $18.18 Range $12.14 - $21.84
Q4 2024
Shares 5,232,000 Value ($000) $98,362 Avg Close $20.59 Range $17.05 - $27.34
Q3 2024
Shares 4,885,000 Value ($000) $94,622 Avg Close $24.41 Range $19.07 - $30.41
Q2 2024
Shares 4,139,000 Value ($000) $107,573 Avg Close $24.57 Range $21.39 - $28.50
Q1 2024
Shares 4,139,000 Value ($000) $118,375 Avg Close $31.99 Range $27.00 - $39.83
Q4 2023
Shares 1,329,000 Value ($000) $40,667 Avg Close $26.56 Range $20.67 - $31.68